Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case
A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
U.S. Becomes First Country to Give mRNA COVID Vaccine to Babies
On June 15, 2022 the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) unanimously advised the FDA staff to grant Moderna and Pfizer/BioNTech an Emergency Use Authorization (EUA) amendment to allow their mRNA COVID vaccines to be given to children under age five and as young as […]
Pfizer, Moderna COVID Shots Likely Linked to Inflammatory Heart Conditions Says CDC Advisory Committee
On June 23, 2021, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) determined that there is a “likely association” between reported cases of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane surrounding the heart) following vaccination with experimental messenger RNA (mRNA) biologics for COVID-19 […]